Enhanced immunosurveillance was accompanied by accumulation of neoantigens over time in MMR-deficient cells, wherein the amount of neoantigens remained stable in MMR-proficient cells, implicating neoantigens generated by MMR deficiency as a direct cause for immune system-mediated elimination of cancer cells (Germano et al. 2017). This evidence concerns the gene MRC1 and cancer.